The biological action of cDNAs from mutated estrogen receptors transfected into breast cancer cells

This publication has 20 references indexed in Scilit:

• Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice
  Breast Cancer Research and Treatment, 1994
• The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain
  Breast Cancer Research and Treatment, 1994
• Investigation of the Mechanism of Tamoxifen-Stimulated Breast Tumor Growth With Nonisomerizable Analogues of Tamoxifen and Metabolites
  JNCI Journal of the National Cancer Institute, 1993
• Point mutation of estrogen receptor (ER) in the ligand-binding domain changes the pharmacology of antiestrogens in ER-negative breast cancer cells stably expressing complementary DNAs for ER
  Molecular Endocrinology, 1992
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Construction of Cell Lines that Express High Levels of the Human Estrogen Receptor and Are Killed by Estrogens
  Molecular Endocrinology, 1990
• Stable transfection of the estrogen receptor cDNA into Hela cells induces estrogen responsiveness of endogenous cathepsin D gene but not of cell growth
  Biochemical and Biophysical Research Communications, 1990
• Tamoxifen metabolites in patients on long-term adjuvant therapy for breast cancer
  European Journal of Cancer and Clinical Oncology, 1990
• Stable transfection of the oestrogen receptor gene into a human osteosarcoma cell line
  Journal of Steroid Biochemistry, 1989
• Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapy
  European Journal of Cancer and Clinical Oncology, 1987